Cannabis for Depression, ADHD or anxiety helps?

For two and a half years, seriously ill people in Germany may be able to receive a doctor’s prescription cannabis drugs or cannabis flowers. Around 95,000 recipes is a British pharmacies in the year 2018. Reasons for such a recipe also anxiety disorders, Tourette’s syndrome and ADHD are, in addition to chronic pain, Multiple sclerosis and epilepsy, such as the techniker Krankenkasse writes.

What is the medical Use of Cannabis has not been explored for many diseases is still sufficient. A group of scientists has now combined in a so-called Meta-analysis, at least in the studies for six different disorders – namely Depression, anxiety disorder, ADHD, psychosis, post-traumatic stress disorder and Tourette’s syndrome. They evaluated a total of 83 studies with approximately 3000 participants.

The conclusion of the group Louisa Degenhardt from the Australian National Drug and Alcohol Research Centre in Sydney:

  • Drugs with the cannabis active ingredient, THC, can probably be used to alleviate the symptoms in patients with anxiety disorders.
  • According to a single study, THC-based drugs in patients with psychosis may exacerbate this further.
  • Apart from this, the present studies cannot conclude that cannabis-containing agents have on the placebo effect beyond the positive effect in the case of the above-mentioned diseases.
  • However, there was at the taking of cannabis-containing drugs more frequent unwanted side-effects. Therefore, more and more people withdrew from the studies prematurely were given instead of a drug-free placebo, a cannabis-based medicine.

Consumption is not recommended

Degenhardt and her Team find fault in that of its publication in the journal “The Lancet Psychiatry,” that larger, high quality studies on the effects of Cannabis on the listed diseases are absent. In most of the evaluated studies, the participants suffered under Multiple sclerosis or severe pain, and additionally have an anxiety disorder or Depression.

You write, therefore, that the use of cannabis is not recommended containing products in the above-mentioned six diseases due to the thin data available and the known risks of consumption. Doctors and patients should, in individual cases, however, decide whether it is necessary to observe positive or negative effects very carefully.

The group holds because of the General interest of medical Cannabis in larger studies is urgently needed to clarify how helpful or risky revenue is, in comparison to the existing therapies.